AMN
$34.50
+$0.01 (0.03%)+0.03%
ClosedLoading chart...
IndexN/A
Market Cap1.34B
Enterprise Value1.38B
Income$-0.00B
Sales$0.69B
EmployeesN/A
P/E11.46
P/S0.22
P/B0.95
P/C2.60
EV/EBITDA13.61
EV/SalesN/A
EPS (ttm)3.01
EarningsN/A
Gross Margin28.35%
Oper. Margin1.21%
Profit Margin-3.51%
Volume0.32M
Shs Outstand0.04B
Change0.03%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.98B | $3.79B | $5.24B | $3.98B | $2.39B | $2.22B | $2.14B | $1.99B |
| Cost of Revenue | $2.06B | $2.54B | $3.53B | $2.67B | $1.60B | $1.48B | $1.44B | $1.34B |
| Gross Profit | $919.38M | $1.25B | $1.72B | $1.31B | $791.78M | $743.47M | $696.38M | $644.42M |
| Gross Margin | 30.81% | 32.98% | 32.74% | 32.87% | 33.08% | 33.46% | 32.60% | 32.41% |
| Operating Expenses | $1.02B | $911.15M | $1.07B | $831.60M | $642.51M | $566.55M | $493.56M | $431.98M |
| Operating Income | $-102.67M | $338.43M | $647.10M | $478.00M | $149.26M | $176.91M | $202.83M | $212.44M |
| Operating Margin | -3.44% | 8.93% | 12.34% | 12.00% | 6.24% | 7.96% | 9.50% | 10.68% |
| Net Income | $-146.98M | $210.68M | $444.05M | $327.39M | $70.67M | $113.99M | $141.74M | $132.56M |
| Net Margin | -4.93% | 5.56% | 8.47% | 8.22% | 2.95% | 5.13% | 6.64% | 6.67% |
| EPS (Basic) | $-3.85 | $5.38 | $9.96 | $6.87 | $1.49 | $2.44 | $2.99 | $2.77 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $2.42B | $2.92B | $2.89B | $3.13B | $2.35B | $1.93B | $1.49B | $1.25B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.71B | $2.09B | $1.84B | $1.97B | $1.53B | $1.19B | $853.73M | $691.43M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $706.62M | $831.26M | $1.04B | $1.16B | $819.68M | $736.74M | $638.99M | $562.53M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $706.62M | $831.26M | $1.04B | $1.16B | $819.68M | $736.74M | $638.99M | $562.53M |
| Total Liabilities & Stockholders Equity | $2.42B | $2.92B | $2.89B | $3.13B | $2.35B | $1.93B | $1.49B | $1.25B |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-146.98M | $210.68M | $444.05M | $327.39M | $70.67M | $113.99M | $141.74M | $132.56M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $320.42M | $372.17M | $653.73M | $305.36M | $256.83M | $224.86M | $226.99M | $115.26M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Kelly Appoints Patrick McCall as Chief Growth OfficerGlobeNewswire Inc. Healthcare Staffing Market Size to Reach USD 76.51 Billion by 2033, Driven by Workforce Shortages and Flexible Care Models – SNS InsiderGlobeNewswire Inc. Top Technology and Security Executives Recognized at the 2025 SoCal ORBIE AwardsGlobeNewswire Inc. AMN Stock Down Despite WorkWise Launch to Enhance Healthcare DeliveryBenzinga Stocks Slip As Oil Prices Climb, 10-Year Yields Cross 4%; Energy Sector Outperforms: What's Driving Markets Monday?Benzinga AMN Healthcare Appoints Jim Hinton to Board of Directors - GlobeNewswireGlobeNewswire Inc. New Strong Sell Stocks for June 26thZacks Investment Research New Report Tracks Revenue Generated by Allied Healthcare ProfessionalsGlobeNewswire Inc.
Show 12 more stories
New Strong Sell Stocks for June 4thZacks Investment Research AMN Healthcare Launches Market Insights into ShiftWise Flex: Empowering Healthcare Talent Strategy with Dynamic IntelligenceGlobeNewswire Inc. Three Reasons to Retain AMN Healthcare (AMN) Stock for NowZacks Investment Research Analyst Ratings For AMN Healthcare ServicesBenzinga AMN Healthcare (AMN) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research Compared to Estimates, AMN Healthcare (AMN) Q1 Earnings: A Look at Key MetricsZacks Investment Research AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research AMN Healthcare Announces First Quarter 2024 ResultsGlobeNewswire Inc. Survey: Nurses See Little Improvement in 2024GlobeNewswire Inc. Exploring Analyst Estimates for AMN Healthcare (AMN) Q1 Earnings, Beyond Revenue and EPSZacks Investment Research Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to DeclineZacks Investment Research New Strong Sell Stocks for April 30thZacks Investment Research
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.
Discover more
You may be interested in